May 18, 2024
Home common stock
Finance

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

  • May 10, 2024

Checkpoint Therapeutics, Inc WALTHAM, Mass., May 10, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the first quarter ended March 31, 2024, and recent corporate updates. James F. Oliviero, President and Chief Executive Officer of Checkpoint, said, “Over the past few

Read More
Finance

Fulton Financial Announces Launch of Common Stock Offering

  • April 29, 2024

LANCASTER, Pa., April 29, 2024–(BUSINESS WIRE)–Fulton Financial Corporation (NASDAQ: FULT) (the “Corporation”) today announced that it commenced an underwritten public offering of shares of its common stock. The Corporation expects to grant the underwriters a 30-day option to purchase additional shares of its common stock. Piper Sandler and BofA Securities are acting as joint book-running

Read More
Finance

Avalo Reports 2023 Financial Results and Provides Business Updates

  • March 29, 2024

Avalo Therapeutics Acquired AVTX-009, Phase-2 ready anti-IL-1β mAb, in March 2024 Increased cash position with private placement financing in March 2024 providing up to $185 million, including initial upfront investment of $115.6 million Topline results from planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa expected in 2026 Expected cash runway into 2027 WAYNE, Pa.

Read More
Investors

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Expensify, Inc.

  • December 31, 2023

NEW YORK, Dec. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Expensify, Inc. (NASDAQ: EXFY) pursuant and/or traceable to the Offering Documents issued in connection with the Company’s Initial Public Offering conducted on or about November 11, 2021 (“IPO” or “Offering”), of

Read More